Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Hard, red 3x3 spot on arm.; Hard, red 3x3 spot on arm.; Itching on arm; Soreness at the time the shot was given.; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE INDURATION (Hard, red 3x3 spot on arm.), VACCINATION SITE ERYTHEMA (Hard, red 3x3 spot on arm.), VACCINATION SITE PAIN (Soreness at the time the shot was given.) and VACCINATION SITE PRURITUS (Itching on arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No medical history information was reported.     On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the time the shot was given.). On 20-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Hard, red 3x3 spot on arm.), VACCINATION SITE ERYTHEMA (Hard, red 3x3 spot on arm.) and VACCINATION SITE PRURITUS (Itching on arm). At the time of the report, VACCINATION SITE INDURATION (Hard, red 3x3 spot on arm.), VACCINATION SITE ERYTHEMA (Hard, red 3x3 spot on arm.), VACCINATION SITE PAIN (Soreness at the time the shot was given.) and VACCINATION SITE PRURITUS (Itching on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Received Treatment including Benadryl cream. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 22-Feb-2021.    This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE INDURATION (Hard, red 3x3 spot on arm.), VACCINATION SITE ERYTHEMA (Hard, red 3x3 spot on arm.), VACCINATION SITE PAIN (Soreness at the time the shot was given.) and VACCINATION SITE PRURITUS (Itching on arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No medical history information was reported.     On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the time the shot was given.). On 20-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Hard, red 3x3 spot on arm.), VACCINATION SITE ERYTHEMA (Hard, red 3x3 spot on arm.) and VACCINATION SITE PRURITUS (Itching on arm). At the time of the report, VACCINATION SITE INDURATION (Hard, red 3x3 spot on arm.), VACCINATION SITE ERYTHEMA (Hard, red 3x3 spot on arm.), VACCINATION SITE PAIN (Soreness at the time the shot was given.) and VACCINATION SITE PRURITUS (Itching on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Received Treatment including Benadryl cream.